Clinical Trial: Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Multi-Center, Open-Label Trial of the Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis

Brief Summary: The overall objective is to evaluate the long-term efficacy, safety and tolerability of repeated Lamazym i.v. treatment in patients 5-21 years of age with alpha-Mannosidosis